# A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia

> **NCT07695597** · PHASE2 · RECRUITING · sponsor: **CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.** · enrollment: 240 (estimated)

## Conditions studied

- Mixed Hyperlipidemia

## Interventions

- **DRUG:** SYH2070
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07695597
- **Lead sponsor:** CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-15
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-09-10
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07695597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07695597, "A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07695597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*